DOLGIT

This brand name is authorized in Austria, Germany, Estonia, Croatia, Lithuania, Poland, Tunisia, Turkey

Active ingredients

The drug DOLGIT contains one active pharmaceutical ingredient (API):

1 Ibuprofen
UNII WK2XYI10QM - IBUPROFEN

Ibuprofen is a propionic acid derivative NSAID that has demonstrated its efficacy by inhibition of prostaglandin synthesis. In humans ibuprofen reduces inflammatory pain, swellings and fever. Furthermore, ibuprofen reversibly inhibits platelet aggregation.

Read about Ibuprofen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
M02AA13 Ibuprofen M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AA Antiinflammatory preparations, non-steroids for topical use
Discover more medicines within M02AA13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: DE Bundesinstitut für Arzneimittel und Medizinprodukte Identifier(s): 02363273, 02363333, 03030674, 03030680, 03834711, 03834728, 08541801, 08544484, 08544774, 08556004, 10315822, 10343238
Country: EE Ravimiamet Identifier(s): 1019933, 1073955
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1006492
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100030191, 100247275
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 3183061
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699587192592, 8699587192608, 8699587351661

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.